Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03866408 · ClinicalTrials.gov registry record · Early Phase 1

Insulin Regulation of Lipolysis and Lipolysis Proteins

A Early Phase 1 study of Obesity, sponsored by Mayo Clinic.

Recruiting
Registry status
Early Phase 1
Development phase
64
Enrollment target
1
Study location

NCT03866408: Recruiting Early Phase 1 study of Obesity, sponsored by Mayo Clinic.

NCT03866408 is a Early Phase 1 study of Obesity that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 64 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03866408, a Early Phase 1 study of Obesity, is actively recruiting participants, sponsored by Mayo Clinic.

RECRUITING
Registry status
Early Phase 1
Development phase
64 participants
Enrollment target
1
Study location

Study Summary

These studies will define the abnormalities in the adipocyte proteins that are involved in the failure of insulin to suppress lipolysis normally in humans with upper body obesity and will help discover the mechanism by which pioglitazone, a medication used to treat type 2 diabetes and improve insulin resistance, improves insulin-regulation of adipocyte fatty acid metabolism.

Conditions Studied

Obesity

Interventions

  • DRUG Placebo
  • DRUG Pioglitazone
  • BEHAVIORAL Immediate weight loss
  • BEHAVIORAL Deferred weight loss

Study Locations (1)

Minnesota

  • Mayo Clinic in Rochester - Rochester

Trial Details

FieldValue
Enrollment Target 64 participants
Start Date 2018-11-12
Est. Completion 2026-12-31
Phase Early Phase 1

Sponsor

Mayo Clinic

2,844 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03866408

The ClinicalTrials.gov registry entry for NCT03866408 describes a study currently listed as recruiting, categorized as Early Phase 1. The registered enrollment target is 64 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (92% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Obesity appearing as the primary indexed condition, and to 4 interventions - of which Placebo is the first listed.

NCT03866408 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT03866408 about?

NCT03866408 is a clinical study titled "Insulin Regulation of Lipolysis and Lipolysis Proteins". These studies will define the abnormalities in the adipocyte proteins that are involved in the failure of insulin to suppress lipolysis normally in humans with upper body obesity and will help discover the mechanism by which pioglitazone, a medication used to treat type 2 diabetes and improve insuli...

What is the current status of trial NCT03866408?

This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 64 participants. The study started on 2018-11-12. Estimated completion is 2026-12-31.

What conditions does trial NCT03866408 study?

This clinical trial studies the following conditions: Obesity.

What interventions are being tested in trial NCT03866408?

The interventions under investigation include: Placebo (DRUG), Pioglitazone (DRUG), Immediate weight loss (BEHAVIORAL), Deferred weight loss (BEHAVIORAL).

Who is sponsoring clinical trial NCT03866408?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03866408 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Obesity

All registered trials for this condition

Minnesota

All trials with a study site in Minnesota

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Related

Compare this shortlist side-by-side

Read our methodology - how this data is sourced, computed, and verified.
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.